Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04534322 |
| Title | Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma (sEAPort) |
| Acronym | sEAPort |
| Recruitment | Approved for marketing |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | No |
| Sponsors | Oncopeptides AB |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |